News &amp; Updates

Live attenuated flu vaccine (A/H1N1, A/H3N2, B/Victoria lineage) – Intranasal spray

Product Highlight - FluMist

Product Highlight - Jeselhy

Pimitespib – Film-coated tablet

Product Highlight - Jeselhy

Sotrovimab for COVID-19 pneumonia lowers risk of death in specific subgroup

In the treatment of hospitalized patients with COVID-19 pneumonia, the use of the neutralizing monoclonal antibody sotrovimab in addition to usual care reduces mortality but only in the subgroup of those with a high baseline serum SARS-CoV-2 antigen concentration, according to the open-label RECOVERY trial.

Sotrovimab for COVID-19 pneumonia lowers risk of death in specific subgroup

FIGO stage >I predicts vulvar cancer recurrence

In patients with vulvar cancer, International Federation of Gynecology and Obstetrics (FIGO) stage >I is associated with regional and distant recurrences, suggests a study. Factors influencing local recurrence have not been identified.

FIGO stage >I predicts vulvar cancer recurrence

Mirikizumab enhances life quality, productivity of CD patients

The use of mirikizumab has improved work productivity and health-related quality of life (HRQoL) in patients with moderately to severely active Crohn’s disease (CD) by week 12, a study has shown. These improvements have been maintained for a year.

Mirikizumab enhances life quality, productivity of CD patients

Regular physical activity helps prevent constipation

People who regularly engage in leisure-time physical activity (PA), 20‒30 min per session for at least 5 days a week, are less likely to develop constipation, suggests a recent study.

Regular physical activity helps prevent constipation

Pancreatic cancer a new Tx target for TTFields?

Pain and quality of life (QoL) outcomes from the phase III PANOVA-3 trial reinforce the role of tumour treating fields (TTFields) therapy when added to a chemotherapeutic regimen consisting of gemcitabine/nab-paclitaxel (GnP) for the treatment of individuals with locally advanced pancreatic adenocarcinoma.

Pancreatic cancer a new Tx target for TTFields?

10 Sep 2025

Drinking artificially sweetened beverages during pregnancy a risk factor for GDM

Pregnant women who frequently drink artificially sweetened beverages are at increased risk of gestational diabetes mellitus (GDM), according to a study.

Drinking artificially sweetened beverages during pregnancy a risk factor for GDM

TALK-IN-TEN: 10 YEARS AND MORE, THINK YOU KNOW SGLT2i?

งานประชุมวิชาการประจำปี ครั้งที่ 41 จัดโดยราชวิทยาลัยอายุรแพทย์แห่งประเทศไทย ช่วงการบรรยายวันที่ 25 เมษายน พ.ศ. 2568 ได้รับการสนับสนุนโดยบริษัท เบอริงเกอร์ อินเกลไฮม์ (ไทย) จำกัด และได้รับเกียรติจากแพทย์เฉพาะทางผู้มีความเชี่ยวชาญ ร่วมนำเสนอและอภิปรายหลักฐานวิชาการตลอดช่วงเวลา 10 ปีของยา empagliflozin ในบทบาทของการรักษาและป้องกันโรคเรื้อรังในปัจจุบัน

TALK-IN-TEN: 10 YEARS AND MORE, THINK YOU KNOW SGLT2i?